Lybalvi Interactions
There are 700 drugs known to interact with Lybalvi (olanzapine/samidorphan), along with 19 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 66 are major, 626 are moderate, and 8 are minor.
- View all 700 medications that may interact with Lybalvi
- View Lybalvi alcohol/food interactions (4)
- View Lybalvi disease interactions (19)
Most frequently checked interactions
View interaction reports for Lybalvi (olanzapine / samidorphan) and the medicines listed below.
- Adderall XR (amphetamine / dextroamphetamine)
- amlodipine
- atorvastatin
- bupropion
- buspirone
- Caplyta (lumateperone)
- clonidine
- famotidine
- gabapentin
- hydroxyzine
- ibuprofen
- Lamictal (lamotrigine)
- lamotrigine
- Latuda (lurasidone)
- levothyroxine
- lithium
- Lithium Carbonate ER (lithium)
- melatonin
- metformin
- montelukast
- olanzapine
- omeprazole
- prazosin
- propranolol
- Prozac (fluoxetine)
- trazodone
- Vitamin D3 (cholecalciferol)
- Vraylar (cariprazine)
- Vyvanse (lisdexamfetamine)
- Zyprexa (olanzapine)
Lybalvi alcohol/food interactions
There are 4 alcohol/food interactions with Lybalvi (olanzapine / samidorphan).
Lybalvi disease interactions
There are 19 disease interactions with Lybalvi (olanzapine / samidorphan) which include:
- dementia
- acute alcohol intoxication
- CNS depression
- NMS
- aspiration
- seizure
- hematologic abnormalities
- hyperglycemia/diabetes
- hypotension
- lipid alterations
- weight gain
- depression
- anticholinergic effects
- hyperprolactinemia
- liver disease
- parkinsonism
- tardive dyskinesia
- ALT elevations
- PKU
Report options
QR code containing a link to this page
More about Lybalvi (olanzapine / samidorphan)
- Lybalvi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (16)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: psychotherapeutic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
